A case report of congenital myasthenic syndrome caused by a mutation in the CHRNE gene in the Iranian population
Iranian Journal of Child Neurology,
Vol. 14 No. 4 (2020),
1 October 2020
,
Page 87-94
https://doi.org/10.22037/ijcn.v14i4.20178
Abstract
Congenital myasthenic syndrome (CMS) refers to a heterogeneous group of inherited disorders, characterized by defective transmission at the neuromuscular junction (NMJ). Patients with CMS showed similar muscle weakness, while other clinical manifestations are mostly dependent on genetic factors. This disease, caused by different DNA mutations, is genetically inherited. It is also associated with mutations of genes at NMJ, involving the acetylcholine receptor (AChR) subunits. Here, we present the case of a five-year-old Iranian boy with CMS, undergoing targeted sequencing of a panel of genes, associated with arthrogryposis and CMS. The patient had six affected relatives in his genetic pedigree chart. The investigations indicated a homozygous single base pair deletion at exon 12 of the CHRNE gene (chr17:4802186delC). This region was conserved across mammalian evolution and was not submitted to the 1000 Genomes Project database. Overall, the CHRNE variant may be classified as a significant variant in the etiology of CMS. It can be suggested that the Iranian CMS population carry regional pathogenic mutations, which can be detected via targeted and whole genome sequencing.
- congenital myasthenic
- CMS
- CHRNE.
How to Cite
References
Palace J, Beeson D. The congenital myasthenic syndromes. Journal of neuroimmunology. 2008;201:2-5.
Hantaï D, Richard P, Koenig J, Eymard B. Congenital myasthenic syndromes. Current opinion in neurology. 2004;17(5):539-51.
Ohno K, Engel AG, Shen X-M, Selcen D, Brengman J, Harper CM, et al. Rapsyn mutations in humans cause endplate acetylcholine-receptor deficiency and myasthenic syndrome. The American Journal of Human Genetics. 2002;70(4):875-85.
Nichols P, Croxen R, Vincent A, Rutter R, Hutchinson M, Newsom‐Davis J, et al. Mutation of the acetylcholine receptor ε‐subunit promoter in congenital myasthenic syndrome. Annals of neurology. 1999;45(4):439-43.
Engel AG, Shen X-M, Selcen D, Sine SM. Congenital myasthenic syndromes: pathogenesis, diagnosis, and treatment. The Lancet Neurology. 2015;14(4):420-34.
Schara U, Della Marina A, Abicht A. Congenital myasthenic syndromes: current diagnostic and therapeutic approaches. Neuropediatrics. 2012;43(04):184-93.
Müller JS, Mihaylova V, Abicht A, Lochmüller H. Congenital myasthenic syndromes: spotlight on genetic defects of neuromuscular transmission. Expert reviews in molecular medicine. 2007;9(22):1-20.
Nicole S, Chaouch A, Torbergsen T, Bauché S, de Bruyckere E, Fontenille M-J, et al. Agrin mutations lead to a congenital myasthenic syndrome with distal muscle weakness and atrophy. Brain. 2014;137(9):2429-43.
Dilena R, Abicht A, Sergi P, Comi GP, Di Fonzo A, Chidini G, et al. Congenital Myasthenic Syndrome Due to Choline Acetyltransferase Mutations in Infants Clinical Suspicion and Comprehensive Electrophysiological Assessment Are Important for Early Diagnosis. Journal of child neurology. 2014;29(3):389-93.
Li H, Homer N. A survey of sequence alignment algorithms for next-generation sequencing. Briefings in bioinformatics. 2010;11(5):473-83.
Meyer LR, Zweig AS, Hinrichs AS, Karolchik D, Kuhn RM, Wong M, et al. The UCSC Genome Browser database: extensions and updates 2013. Nucleic acids research. 2013;41(D1):D64-D9.
McKenna A, Hanna M, Banks E, Sivachenko A, Cibulskis K, Kernytsky A, et al. The Genome Analysis Toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data. Genome research. 2010;20(9):1297-303.
Li H, Durbin R. Fast and accurate long-read alignment with Burrows–Wheeler transform. Bioinformatics. 2010;26(5):589-95.
Engel AG. Current status of the congenital myasthenic syndromes. Neuromuscular Disorders. 2012;22(2):99-111.
Abicht A, Dusl M, Gallenmüller C, Guergueltcheva V, Schara U, Della Marina A, et al. Congenital myasthenic syndromes: Achievements and limitations of phenotype‐guided gene‐after‐gene sequencing in diagnostic practice: A study of 680 patients. Human mutation. 2012;33(10):1474-84.
Müller JS, Baumeister SK, Schara U, Cossins J, Krause S, Hagen Mvd, et al. CHRND mutation causes a congenital myasthenic syndrome by impairing co-clustering of the acetylcholine receptor with rapsyn. Brain. 2006;129(10):2784-93.
- Abstract Viewed: 176 times